Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Acta Tropica
|
April 1, 2018
In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption
Elizabeth Valdivieso, Fabiola Mejías, Carlos Torrealba, et al.
Human Pathology
|
September 28, 2013
Primary cutaneous carcinosarcoma: insights into its clonal origin and mutational pattern expression analysis through next-generation sequencing
Alberto E Paniz Mondolfi, George Jour, Matthew Johnson, et al.
Antimicrobial Agents and Chemotherapy
|
April 18, 2012
In vitro anti-Trypanosoma cruzi activity of dronedarone, a novel amiodarone derivative with an improved safety profile
Gustavo Benaim, Vanessa Hernandez-Rodriguez, Sheira Mujica-Gonzalez, et al.
Virchows Archiv : an International Journal of Pathology
|
July 18, 2014
Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing
Alberto Paniz-Mondolfi, Rajesh Singh, George Jour, et al.
Antimicrobial Agents and Chemotherapy
|
February 5, 2014
Dronedarone, an amiodarone analog with improved anti-Leishmania mexicana efficacy
Gustavo Benaim, Paola Casanova, Vanessa Hernandez-Rodriguez, et al.
Cancer Chemotherapy and Pharmacology
|
May 24, 2011
The marine sponge toxin agelasine B increases the intracellular Ca(2+) concentration and induces apoptosis in human breast cancer cells (MCF-7)
Adriana A Pimentel, Pimali Felibertt, Felipe Sojo, et al.
ACS Infectious Diseases
|
May 6, 2025
Anti-Parasitics with a Triple Threat: Targeting Parasite Enzymes, the Proton Motive Force, and Host Cell-Mediated Killing
Akanksha M Pandey, Satish R Malwal, Mariana Valladares-Delgado, et al.
Journal of Medicinal Chemistry
|
February 3, 2006
Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole
Gustavo Benaim, John M Sanders, Yael Garcia-Marchán, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 23, 2023
Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
Joyce E Gutiérrez, Hegira Ramírez, Esteban Fernandez-Moreira, et al.
Antimicrobial Agents and Chemotherapy
|
January 14, 2015
SQ109, a new drug lead for Chagas disease
Phercyles Veiga-Santos, Kai Li, Lilianne Lameira, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Acta Tropica
|
April 1, 2018
In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption
Elizabeth Valdivieso, Fabiola Mejías, Carlos Torrealba, et al.
Human Pathology
|
September 28, 2013
Primary cutaneous carcinosarcoma: insights into its clonal origin and mutational pattern expression analysis through next-generation sequencing
Alberto E Paniz Mondolfi, George Jour, Matthew Johnson, et al.
Antimicrobial Agents and Chemotherapy
|
April 18, 2012
In vitro anti-Trypanosoma cruzi activity of dronedarone, a novel amiodarone derivative with an improved safety profile
Gustavo Benaim, Vanessa Hernandez-Rodriguez, Sheira Mujica-Gonzalez, et al.
Virchows Archiv : an International Journal of Pathology
|
July 18, 2014
Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing
Alberto Paniz-Mondolfi, Rajesh Singh, George Jour, et al.
Antimicrobial Agents and Chemotherapy
|
February 5, 2014
Dronedarone, an amiodarone analog with improved anti-Leishmania mexicana efficacy
Gustavo Benaim, Paola Casanova, Vanessa Hernandez-Rodriguez, et al.
Cancer Chemotherapy and Pharmacology
|
May 24, 2011
The marine sponge toxin agelasine B increases the intracellular Ca(2+) concentration and induces apoptosis in human breast cancer cells (MCF-7)
Adriana A Pimentel, Pimali Felibertt, Felipe Sojo, et al.
ACS Infectious Diseases
|
May 6, 2025
Anti-Parasitics with a Triple Threat: Targeting Parasite Enzymes, the Proton Motive Force, and Host Cell-Mediated Killing
Akanksha M Pandey, Satish R Malwal, Mariana Valladares-Delgado, et al.
Journal of Medicinal Chemistry
|
February 3, 2006
Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole
Gustavo Benaim, John M Sanders, Yael Garcia-Marchán, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 23, 2023
Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
Joyce E Gutiérrez, Hegira Ramírez, Esteban Fernandez-Moreira, et al.
Antimicrobial Agents and Chemotherapy
|
January 14, 2015
SQ109, a new drug lead for Chagas disease
Phercyles Veiga-Santos, Kai Li, Lilianne Lameira, et al.
Page
of 6